By Bonnie Eslinger ( June 27, 2023, 10:11 PM EDT) -- Gilead and Teva "cut a pay-off deal" to keep prices for two HIV drugs as "expensive as possible for as long as possible" and should be ordered to return overcharges totaling $3.6 billion, a lawyer for drug purchasers said Tuesday at the conclusion of a California federal antitrust trial....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.